(Q37691163)

English

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis

scientific article published on 25 October 2013

Statements

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis (English)
Melvin Churchill
Luis Flores-Suarez
Mario H Cardiel
Kristine Phillips
Jeffrey L Kaine
David Salinger
Chris B Russell

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit